Bonus Episode: Haematopoietic Stem Cell Transplant (HSCT) in Diffuse Cutaneous Systemic Sclerosis (dcSSc) and Potential Role of FCR001, an Investigational Allogeneic Cell Therapy

The EMJ Podcast: Insights For Healthcare Professionals

Nov 10 2022 • 36 mins

This podcast explores hematopoietic stem cell transplant in diffuse cutaneous systemic sclerosis (dcSSc) and the potential role of FCR001, an investigational allogeneic cell therapy. We are pleased to be joined by leading sclerosis expert Dinesh Khanna MD, MSc.  Dr. Khanna is the Sclerosis Program Director at University of Michigan, USA, Dr. Khanna discusses the symptoms, severity, and progressiveness of sclerosis, focusing on dcSSc. Dr. Khanna further explores the current treatment options, the unmet medical need, and the future of FCR001 and allogeneic stem cell transplants.

This podcast is funded and developed by Talaris Therapeutics, Inc. Talaris Therapeutics is a late-clinical stage cell therapy company that is developing an investigational allogeneic stem cell therapy.